Publications by authors named "Ellin Febrina"

Article Synopsis
  • Chitosan nanoparticles (CSNPs) are effective for targeted and controlled drug delivery due to their biodegradable and biocompatible nature, as well as their low toxicity and ease of production.
  • The encapsulation of drugs within these nanoparticles enhances benefits like improved bioavailability, reduced side effects, and the potential for controlled release and targeted therapy.
  • The review highlights recent advancements in creating CSNPs with higher drug loading capacities, addressing challenges in current nanoparticle systems, and exploring different synthesis methods and materials for better drug delivery applications.*
View Article and Find Full Text PDF

Background: Diabetes mellitus is a complex metabolic disorder that has an enormous impact on people's quality of life and health. Although there is no doubt about the effectiveness of oral hypoglycemic agents combined with lifestyle management in controlling diabetes, no individual has ever been reported to have been completely cured of the disease. Globally, many medicinal plants have been used for the management of diabetes in various traditional systems of medicine.

View Article and Find Full Text PDF

Dipeptidyl peptidase IV (DPP-IV) is an enzyme responsible for the degradation of the incretin hormone glucagon-like peptide-1 (GLP-1). DPP-IV plays a significant role in regulating blood glucose levels by modulating the activity of GLP-1. In the context of diabetes, DPP-IV inhibitors effectively block the activity of DPP-IV, hence mitigating the degradation of GLP-1.

View Article and Find Full Text PDF

Context: Irrational use of antibacterial drugs in Community Health-Care Centers (CHCs) may lead to increased resistance, morbidity, and mortality.

Aims: The aim of this study was to determine patterns of antibacterial use at CHCs in a district of Indonesia and use this as data for an antibiotic policy.

Settings And Design: The observational-descriptive study was conducted in a district of Indonesia to obtain antibacterial use from 2008 to 2010.

View Article and Find Full Text PDF